Table 3.

Clinical outcomes

Pt #	Age	Gender	Cancer	Performance status (ECOG)	Prior chemos	PFS¤	OS† (mos.)
1	62	F	Gastric	0	1	5	21
2	57	F	Breast	0	4	2	27
3	35	M	Colon	1	7	2	19
4*	40	F	Gastric	1	1	6	22
5	60	F	Pancreatic	1	1	2	18
6*	57	M	Colon	0	2	30+	30+
7*	56	F	Appendiceal	1	2	29+	29+
8	67	F	Breast	1	3	6	25+
9	50	M	Colon	0	2	2	15
10*	61	F	Gastric	0	2	4	18
11*	61	M	Colon	0	3	3	22+
12	48	F	Colon	1	3	2	14
13	52	F	Colon	1	3	4	23+
14	65	F	Pancreatic	0	2	2	13
15*	53	M	Appendiceal	1	5	2	22+
16	63	F	Lung	1	7	2	12
17	67	M	Colon	1	3	2	11
18	56	F	Lung	1	2	1	N/A
19	66	M	Esophageal adenocarcinoma	1	1	4	20+
20	38	F	Colon	1	1	2	18
21	70	M	Colon	0	2	2	12
22	42	F	Ovarian	1	1	18	21
23*	40	F	Rectal	1	1	9	17+
24	57	F	Ovarian	1	2	2	6
25*	53	F	Ovarian	0	2	19+	19+

^*Patient had no radiographic evidence of disease at baseline.

^¤PFS, progression free survival. Plus sign in this column indicates patient remains on trial.

^†OS, overall survival. Plus sign in this column indicates patient alive at time of last contact.